Skip to main content
NewslettersWatchlist

Sernova Corp(SVA-T)
TSX

Today's Change
Real-Time Last Update

SVA FINAL DEADLINE MONDAY: ROSEN, A LEADING NATIONAL FIRM, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA

PR Newswire - Tue Oct 11, 2022

NEW YORK, Oct. 11, 2022 /PRNewswire/ --

WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of the stock of Sinovac Biotech Ltd. (NASDAQ: SVA) between April 11, 2016 and February 22, 2019, both dates inclusive (the "Class Period"), of the October 17, 2022 lead plaintiff deadline in the lawsuit against 1Globe Capital LLC and certain of its officers.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

globe investor
Chevron tops Tesla as most-shorted stock in April, says Hazeltree
The Chevron Pascagoula Refinery is pictured in Pascagoula, Mississippi on Sept. 4, 2018.
market news
The close: Nasdaq at record high after Fed chair’s comments but TSX dips for third day
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 8.
market news
The close: S&P 500, TSX slip as investors await inflation data; meme rally reignites
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 8.
report on business
Shopify executive earned US$76-million in 2023, far outpacing CEO’s compensation
Kaz Nejatian, COO of Shopify, speaks at the Collision conference in Toronto, Wednesday, June 28, 2023. THE CANADIAN PRESS/Chris Young
inside the market
Advantage Energy director buys as stock rallies
Ted Dixon
market news
The close: S&P 500 higher but TSX slips as traders await key U.S. inflation data
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 8, 2024. REUTERS/Brendan McDermid/File Photo
opinion
You’ve heard of dollar-cost averaging. How about trying dollar-cost selling?
Nancy Woods
inside the market
How pro money managers are balancing exposure to Canadian and U.S. stocks
Rob Carrick

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).